BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.070
-0.100 (-4.61%)
At close: Apr 28, 2026, 4:00 PM EDT
2.090
+0.020 (0.97%)
After-hours: Apr 28, 2026, 4:00 PM EDT
BioNexus Gene Lab Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 5 | 9 | 5 | 9 | 165 | 365 | |
| Market Cap Growth | 28.34% | 85.79% | -46.33% | -94.33% | -54.75% | 54.35% | |
| Enterprise Value | 1 | 7 | 1 | 3 | 164 | 363 | |
| Last Close Price | 2.07 | 3.95 | 2.80 | 5.30 | 114.00 | 255.60 | |
| PE Ratio | - | - | - | - | - | 485.24 | |
| PS Ratio | 0.67 | 1.26 | 0.53 | 0.96 | 15.10 | 27.29 | |
| PB Ratio | 0.58 | 1.08 | 0.60 | 0.97 | 24.76 | 50.80 | |
| P/TBV Ratio | 0.58 | 1.08 | 0.60 | 0.97 | 24.76 | 50.80 | |
| P/FCF Ratio | - | - | - | - | 331.62 | 60792.56 | |
| P/OCF Ratio | - | - | - | - | 299.07 | 39809.47 | |
| EV/Sales Ratio | 0.16 | 0.90 | 0.12 | 0.34 | 14.97 | 27.17 | |
| EV/EBITDA Ratio | - | - | - | - | - | 316.52 | |
| EV/EBIT Ratio | - | - | - | - | - | 343.88 | |
| EV/FCF Ratio | - | - | - | - | 328.74 | 60523.49 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 0.07 | |
| Debt / FCF Ratio | - | - | - | - | 0.11 | 12.83 | |
| Net Debt / Equity Ratio | -0.44 | -0.44 | -0.50 | -0.60 | -0.31 | -0.28 | |
| Net Debt / EBITDA Ratio | 1.28 | 1.28 | 2.31 | 1.96 | 15.97 | -1.78 | |
| Net Debt / FCF Ratio | 2.03 | 2.03 | 1.79 | 2.93 | -4.14 | -341.22 | |
| Asset Turnover | 0.75 | 0.75 | 0.87 | 0.97 | 1.19 | 1.36 | |
| Inventory Turnover | 6.14 | 6.14 | 6.51 | 7.98 | 7.74 | 8.23 | |
| Quick Ratio | 9.00 | 9.00 | 3.10 | 4.24 | 2.52 | 2.39 | |
| Current Ratio | 10.46 | 10.46 | 3.81 | 4.93 | 3.01 | 3.07 | |
| Return on Equity (ROE) | -35.24% | -35.24% | -17.78% | -32.21% | -5.14% | 10.86% | |
| Return on Assets (ROA) | -19.68% | -19.68% | -10.86% | -18.85% | -1.50% | 6.70% | |
| Return on Invested Capital (ROIC) | -69.20% | -69.07% | -47.15% | -71.66% | -4.53% | 16.67% | |
| Return on Capital Employed (ROCE) | -35.50% | -35.50% | -22.40% | -31.10% | -3.30% | 14.60% | |
| Earnings Yield | -59.65% | -31.96% | -31.80% | -28.08% | -0.22% | 0.21% | |
| FCF Yield | -37.48% | -20.09% | -46.17% | -21.05% | 0.30% | 0.00% | |
| Buyback Yield / Dilution | -4.20% | -4.20% | -12.24% | -10.17% | -0.99% | -66.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.